Showing results (31-40 of 90) with videos related to
Sort By:
Pageof 9
Molecular Genetics and Metabolism|March 25, 2021
The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44Orly Goldstein, Mali Gana-Weisz, Reut Attar, et al.Brain Structure & Function|July 13, 2016
A cognitive fMRI study in non-manifesting LRRK2 and GBA carriersNoa Bregman, Avner Thaler, Anat Mirelman, et al.Journal of Parkinson'S Disease|February 17, 2025
P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onsetShachar Shani, Mali Gana-Weisz, Anat Bar-Shira, et al.Parkinsonism & Related Disorders|April 28, 2023
Variants in PSMB9 and FGR differentially affect Parkinson's disease risk in GBA and LRRK2 mutation carriersShachar Shani, Orly Goldstein, Mali Gana-Weisz, et al.Parkinsonism & Related Disorders|September 8, 2017
Reduced mind wandering in patients with Parkinson's diseaseTal Geffen, Avner Thaler, Gadi Gilam, et al.Movement Disorders Clinical Practice|May 19, 2022
Advanced-Stage Parkinson's Disease: From Identification to Characterization Using a Nationwide DatabaseYael Barer, Tanya Gurevich, Gabriel Chodick, et al.Human Brain Mapping|February 23, 2019
Network abnormalities among non-manifesting Parkinson disease related LRRK2 mutation carriersYael Jacob, Keren Rosenberg-Katz, Tanya Gurevich, et al.Genes|January 23, 2024
MAPT Locus in Parkinson's Disease Patients of Ashkenazi Origin: A Stratified AnalysisShachar Shani, Mali Gana-Weisz, Anat Bar-Shira, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2013
Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutationAnat Mirelman, Talia Heman, Kira Yasinovsky, et al.Plos One|April 14, 2017
DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriersMoran Artzi, Einat Even-Sapir, Hedva Lerman Shacham, et al.Pageof 9